Literature DB >> 24847369

Parkinson's disease guidelines for pharmacists.

Tejal Patel1, Feng Chang1.   

Abstract

Entities:  

Year:  2014        PMID： 24847369      PMCID： PMC4025881          DOI： 10.1177/1715163514529740

Source DB:  PubMed          Journal:  Can Pharm J (Ott)        ISSN： 1715-1635


× No keyword cloud information.
  6 in total

Review 1.  Current concepts in the diagnosis and management of Parkinson's disease.

Authors:  Mark Guttman; Stephen J Kish; Yoshiaki Furukawa
Journal:  CMAJ       Date:  2003-02-04       Impact factor: 8.262

Review 2.  Parkinson's disease. First of two parts.

Authors:  A E Lang; A M Lozano
Journal:  N Engl J Med       Date:  1998-10-08       Impact factor: 91.245

Review 3.  Parkinson's disease. Second of two parts.

Authors:  A E Lang; A M Lozano
Journal:  N Engl J Med       Date:  1998-10-15       Impact factor: 91.245

4.  Canadian Guidelines on Parkinson's Disease.

Authors:  David Grimes; Joyce Gordon; Barbara Snelgrove; Ivy Lim-Carter; Edward Fon; Wayne Martin; Marguerite Wieler; Oksana Suchowersky; Alex Rajput; Anne L Lafontaine; Jon Stoessl; Elena Moro; Kerrie Schoffer; Janis Miyasaki; Doug Hobson; Minoo Mahmoudi; Susan Fox; Ron Postuma; Hrishikesh Kumar; Mandar Jog
Journal:  Can J Neurol Sci       Date:  2012-07       Impact factor: 2.104

5.  Burden of parkinsonism: a population-based study.

Authors:  Mark Guttman; Pamela M Slaughter; Marc-Erick Theriault; Donald P DeBoer; C David Naylor
Journal:  Mov Disord       Date:  2003-03       Impact factor: 10.338

Review 6.  The scientific and clinical basis for the treatment of Parkinson disease (2009).

Authors:  C Warren Olanow; Matthew B Stern; Kapil Sethi
Journal:  Neurology       Date:  2009-05-26       Impact factor: 9.910
  6 in total
  10 in total

1.  Practice recommendations for Parkinson's disease: Assessment and management by community pharmacists.

Authors:  Tejal Patel; Feng Chang
Journal:  Can Pharm J (Ott)       Date:  2015-05

2.  Pharmacy students are vital to the future of the profession / Les étudiants en pharmacie moteur du changement.

Authors:  Ross T Tsuyuki
Journal:  Can Pharm J (Ott)       Date:  2015-05

Review 3.  Pimavanserin: A Novel Drug Approved to Treat Parkinson's Disease Psychosis.

Authors:  Amanda K Kitten; Sarah A Hallowell; Stephen R Saklad; Kirk E Evoy
Journal:  Innov Clin Neurosci       Date:  2018-02-01

4.  Drug Safety Analysis in a Real-Life Cohort of Parkinson's Disease Patients with Polypharmacy.

Authors:  Saskia Müller-Rebstein; Claudia Trenkwalder; Jens Ebentheuer; Wolfgang H Oertel; Carsten Culmsee; Günter U Höglinger
Journal:  CNS Drugs       Date:  2017-12       Impact factor: 5.749

5.  Lower Limb Rigidity Is Associated with Frequent Falls in Parkinson's Disease.

Authors:  J Lucas McKay; Madeleine E Hackney; Stewart A Factor; Lena H Ting
Journal:  Mov Disord Clin Pract       Date:  2019-06-06

Review 6.  Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy.

Authors:  Mariana Babayeva; Haregewein Assefa; Paramita Basu; Sanjeda Chumki; Zvi Loewy
Journal:  Parkinsons Dis       Date:  2016-12-05

Review 7.  Guidelines for dementia or Parkinson's disease with depression or anxiety: a systematic review.

Authors:  Zahra Goodarzi; Bria Mele; Selynne Guo; Heather Hanson; Nathalie Jette; Scott Patten; Tamara Pringsheim; Jayna Holroyd-Leduc
Journal:  BMC Neurol       Date:  2016-11-25       Impact factor: 2.474

Review 8.  Gastrointestinal dysfunction in idiopathic Parkinsonism: A narrative review.

Authors:  Mehri Salari; Emad Fayyazi; Omid Mirmosayyeb
Journal:  J Res Med Sci       Date:  2016-12-26       Impact factor: 1.852

Review 9.  Management of Parkinson's Disease 20 Years from Now: Towards Digital Health Pathways.

Authors:  Jochen Klucken; Rejko Krüger; Peter Schmidt; Bastiaan R Bloem
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

10.  Incidence of heart valve disease in women treated with the ergot-derived dopamine agonist bromocriptine.

Authors:  Marianne F Clausen; Rasmus Rørth; Christian Torp-Pedersen; Lucas Malta Westergaard; Peter E Weeke; Gunnar Gislason; Lars Køber; Emil Fosbøl; Søren Lund Kristensen
Journal:  BMC Cardiovasc Disord       Date:  2021-12-28       Impact factor: 2.298
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.